Kids who use smartphones, tablets, or video games more than 7 hours a day appeared to have premature thinning of the cortex, NIH researchers said on the “60 Minutes” TV progam. Check out MedPage Today’s coverage of other findings from the study.
Acute flaccid myelitis, the mysterious paralyzing disease affecting mainly children, reached a record count of 158 confirmed cases in 36 states. (AP News)
Epilepsy patients in high-crime neighborhoods had more seizures. (Chicago Tribune)
Can personalized medicine solve Alzheimer’s? Cleveland Clinic neurologists make a case. (U.S. News & World Report)
Opening the door for targeted treatment, researchers discovered they could classify Alzheimer’s patients into six biologically coherent subgroups. (Molecular Psychiatry)
And, a photographer looked at Alzheimer’s in a more intimate way, chronicling his father’s experience with the disease. (NPR)
The FDA cleared the reSET-O mobile app that provides cognitive behavioral therapy, as an adjunct to buprenorphine and contingency management, for people with opioid use disorder.
Cultural barriers and perceived stigma may block Hispanic epilepsy patients from seeking medical care. (JAMA Neurology)
LMTX, a protein aggregation inhibitor for the treatment of frontotemporal dementia, received FDA orphan drug designation, drug maker TauRx Therapeutics announced.
And, after a failed phase II trial, Axovant abandoned nelotanserin for REM sleep behavior disorder in Lewy body dementia patients.
Is the U.S. ready for heroin-assisted treatment? (The Atlantic)